Health Care Archives - Page 386 of 478

1 minute read

Small Eye-Focused Gene Therapy Company Applied Genetic Goes Private In $24M Deal

October 24, 7:40 AM

The newly established portfolio company of Syncona Limited has agreed to acquire Applied Genetic Technologies Corp (NASDAQ:AGTC) for approximately $23.5 million ($0.34 per…

AGTC

1 minute read

Merck’s Antiviral Therapy Shows Efficacy In Prevention of Cytomegalovirus In Kidney Transplant Patients

By Vandana Singh

October 24, 5:47 AM

Merck & Co Inc (NYSE:MRK) highlighted findings from a Phase 3 trial of Prevymis (letermovir) compared to valganciclovir for…

MRK

1 minute read

Analyst Downgrades Immunic After Lack of Details Drive Uncertainty

By Vandana Singh

October 21, 3:14 PM

SVB Leerink has downgraded Immunic Inc (NASDAQ:IMUX) to Market Perform from Outperform following disappointing initial data from the highly anticipated Phase 1b proof-of-concept…

IMUX

1 minute read

Analyst Moves To Sidelines After Jazz Pharma Deal Shifts Zymeworks To Early Stage Pipeline

By Vandana Singh

October 21, 1:35 PM

SVB Leerink downgraded Zymeworks Inc (NASDAQ:ZYME) to Market Perform with a price target of $8, down from $19 following the recent divestiture of…

JAZZ

1 minute read

Children’s Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids

By Vandana Singh

October 21, 12:10 PM

Physicians are reporting a sharp increase in cases of the respiratory syncytial virus (RSV), creating capacity issues in several children's hospitals in the U.S. before the typically busier winter months.

AZN

1 minute read

Immunic’s Early Cut Data From Psoriasis Candidate Failed To Show Desired Activity Signal Over Placebo

By Vandana Singh

October 21, 6:52 AM

Immunic Inc (NASDAQ:IMUX) announced the outcome of a pre-planned interim group-level data analysis of its phase 1b trial of IMU-935 in…

IMUX

1 minute read

Analyst Bullish On SQZ Biotech’s Technology For Solving Cell Therapy Challenges

By Vandana Singh

October 20, 3:06 PM

HC Wainwright initiated coverage on SQZ Biotechnologies Company (NYSE:SQZ) with a Buy rating and a price target of $10. SQZ is focused…

RHHBY

1 minute read

HC Wainwright Says Talaris’ Technology Unprecedented In Cell Therapy Space

By Vandana Singh

October 20, 2:27 PM

HC Wainwright initiated coverage on Talaris Therapeutics Inc (NASDAQ:TALS) with a Buy rating and a price target of $18. Talaris leverages its…

TALS

1 minute read

Xeris Biopharma Posts Encouraging Data From Reformulated Thyroid Hormone Deficiency Treatment In Healthy Participants

By Vandana Singh

October 20, 10:28 AM

Xeris Biopharma Holdings Inc (NASDAQ:XERS) announced topline results from its Phase 1 study of subcutaneous (SC) levothyroxine (XP-8121) in healthy adult…

XERS

1 minute read

European Regulatory Authority Backs Approval For Moderna’s New Omicron Targeted COVID-19 Booster

By Vandana Singh

October 19, 3:04 PM

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has backed conditional approval for Moderna Inc’s (NASDAQ:MRNA)…

MRNA